Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Share Pledge

Promoters pledged 2,80,08,979 equity shares (6.66%) to Catalyst Trusteeship as debenture trustee. The pledge secures existing debenture obligations with no new capital involved.

Krishna Institute of Medical Sciences Capacity Expansion

Krishna Institute of Medical Sciences Ltd entered an Operations and Management Agreement with Sarvottam Health Care Pvt Ltd for 5+5 years to manage their operations.

Execution

5 years with an extension for a further period of 5 years

Krishna Institute of Medical Sciences Earnings Call Transcript: Key Takeaways

KIMS delivered strong EBITDA margins despite lower ARPOB compared to peers, driven by lean operational efficiency and high patient volumes.

Krishna Institute of Medical Sciences Investor Presentation: Key Takeaways

KIMS reported strong Q1 FY27 results with consolidated operating revenue growth of 35.3% YoY and 9.8% QoQ, driven by expansion and higher occupancy in core clusters.

Krishna Institute of Medical Sciences Q1 FY27 Results: Net Profit ₹37.4 Cr, Down 56.0% YoY

Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,180 Cr (+35.3% YoY) and net profit of ₹37.4 Cr (-56.0% YoY) for Q1 FY27.

Key figure

Net profit ₹37.4 Cr · -56.0% YoY

Krishna Institute of Medical Sciences Earnings Call: Key Takeaways

KIMS Hospitals Q4 FY26 earnings call highlighting robust 35.3% revenue growth to INR 1,084cr, despite EBITDA margin contraction to 19.9% due to heavy expansion and new unit drags.

Krishna Institute of Medical Sciences Earnings Call: Key Takeaways

KIMS delivered FY26 revenue growth of 28.2% YoY, reaching ₹39,308 Mn. Expansion continues across Telangana, AP, Maharashtra, and Kerala with a vision to reach 8600+ beds.